Novartis Venture Fund (NVF)

Funding rounds backed by Novartis Venture Fund (NVF).

Export CSV
Funding disclosed in full
$107M
Median round
$107M
Rounds in calculation
1
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
EpiBiologics

Develops novel bispecific antibodies for targeted degradation of extracellular proteins in oncolo...

$107MSeries BBiotechUnited States
13 participantsAulis CapitalAvego BioScience CapitalCodon CapitalDigitalis VenturesGV (Google Ventures)IncJohnson & Johnson Innovation – JJDCMission BioCapitalNovartis Venture Fund (NVF)Polaris PartnersSamsara BioCapitalTaiho VenturesVivo Capital